Qingdao Baheal Medical INC. (301015.SZ)
CNY 26.67
(-0.34%)
CNY 26.67
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 612.81 Million | 309.05 Million | 184.19 Million | -113.35 Million | 45.96 Million | 55.5 Million |
| Net Income | 656.3 Million | 506.59 Million | 421.64 Million | 272.71 Million | 209.87 Million | 258.1 Million |
| Depreciation & Amortization | 58.02 Million | 61.53 Million | 53.18 Million | 22.79 Million | 22 Million | 22.78 Million |
| Deferred income taxes | -15.1 Million | -11.74 Million | 6.28 Million | 1.16 Million | 8.16 Million | -10.63 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -133.43 Million | -308.81 Million | -344.75 Million | -493.12 Million | -254.02 Million | -254.58 Million |
| Other non-cash items | 296.51 Million | 493.35 Million | 499.15 Million | 624.16 Million | 360.93 Million | 340.05 Million |
| Investing Cash Flow | -162.11 Million | -156.08 Million | -77.18 Million | -46.1 Million | 701.26 Thousand | -69.97 Million |
| Investments in PPE | -129.23 Million | -105.32 Million | -27.48 Million | -16.35 Million | -2.95 Million | -15.73 Million |
| Acquisitions | 22.93 Million | -32.52 Million | -45.21 Million | 349.78 Thousand | 29.83 Thousand | - |
| Investment purchases | -94.06 Million | -70.65 Million | -56.47 Million | -584.16 Million | -353.46 Million | -1.46 Billion |
| Sales/Maturities of investments | 38.25 Million | 52.41 Million | 52 Million | 553.32 Million | 356.46 Million | 1.43 Billion |
| Other Investing Activities | -470.69 Thousand | -1.86 Million | - | 735.73 Thousand | 625.83 Thousand | -24.82 Million |
| Financing Cash Flow | -254.21 Million | -508.12 Million | 89.49 Million | 305.81 Million | 239.29 Million | -99.75 Million |
| Debt repayment | -206.81 Million | -84.12 Million | -186.19 Million | -237.6 Million | -385.34 Million | -61.37 Million |
| Dividends payments | -400.12 Million | -350.24 Million | -55.72 Million | -89.77 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31.93 Million | -39.93 Million | 301.78 Million | 157.97 Million | -146.05 Million | -161.12 Million |
| Accounts receivables | -47.09 Million | -386.89 Million | -373.67 Million | -542.57 Million | -296.03 Million | -227.15 Million |
| Accounts payables | -56.56 Million | 148.45 Million | 39.61 Million | 175.54 Million | 195.07 Million | 68.94 Million |
| Inventory | -29.77 Million | -70.36 Million | -10.88 Million | -128.42 Million | -156 Million | -96.44 Million |
| Other working capital | -71.66 Million | - | 196.89 Thousand | 2.33 Million | 2.95 Million | 70.06 Thousand |
| Cash at beginning of period | 991.26 Million | 1.26 Billion | 1.1 Billion | 1.16 Billion | 785.23 Million | 899.46 Million |
| Cash at end of period | 1.17 Billion | 991.26 Million | 1.26 Billion | 1.1 Billion | 1.16 Billion | 785.23 Million |
| Capital Expenditure | -129.23 Million | -105.32 Million | -27.48 Million | -16.35 Million | -2.95 Million | -15.73 Million |
| Effect of forex changes on cash | 719.82 Thousand | 5.87 Million | -1.17 Million | -1.08 Million | - | - |
| Net cash flow / Change in cash | 187.28 Million | -274.86 Million | 158.94 Million | -55.67 Million | 377.61 Million | -114.23 Million |
| Free Cash Flow | 483.58 Million | 203.72 Million | 156.7 Million | -129.7 Million | 43 Million | 39.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 272.3 Million | 202.69 Million | 165.99 Million | 656.3 Million | 162.15 Million | 191.67 Million |
| Depreciation & Amortization | - | 13.66 Million | 13.66 Million | 58.02 Million | 13.22 Million | 13.22 Million |
| Deferred income taxes | - | - | - | -15.1 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 23.06 Million | - | -133.43 Million | - | - |
| Other non-cash items | -57.5 Million | 28.6 Million | -29.55 Million | 296.51 Million | 150.17 Million | -162.62 Million |
| Investing Cash Flow | -451.63 Million | -41.89 Million | -21.87 Million | -162.11 Million | -35.92 Million | -27.95 Million |
| Investments in PPE | -152.04 Million | -18.31 Million | -27.35 Million | -129.23 Million | -58.92 Million | -30.64 Million |
| Acquisitions | 998.35 Thousand | - | 721.65 Thousand | 22.93 Million | 19.03 Million | 2.9 Million |
| Investment purchases | -547.09 Million | -23.58 Million | - | -94.06 Million | -34.5 Million | - |
| Sales/Maturities of investments | 247.48 Million | 4.96 Million | 4.76 Million | 38.25 Million | 37.99 Million | 255.02 Thousand |
| Other Investing Activities | 18.34 Thousand | -18.61 Million | - | -470.69 Thousand | 470.69 Thousand | -470.69 Thousand |
| Financing Cash Flow | -573.94 Million | 226.01 Million | 203.61 Million | -254.21 Million | -33.13 Million | -375.9 Million |
| Debt repayment | -93.17 Million | -630.38 Million | -220.9 Million | -206.81 Million | -36.65 Million | -388.16 Million |
| Dividends payments | -37.19 Million | -400.51 Million | -4.2 Million | -400.12 Million | -400.12 Million | -7.02 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -443.57 Million | -2.47 Million | -17.29 Million | -31.93 Million | -495.39 Million | 3.39 Million |
| Accounts receivables | - | -41.11 Million | - | -47.09 Million | - | - |
| Accounts payables | - | - | - | -56.56 Million | - | - |
| Inventory | - | 64.17 Million | - | -29.77 Million | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.71 Billion | 1.51 Billion | 1.17 Billion | 991.26 Million | 1 Billion | 1.37 Billion |
| Cash at end of period | 1.03 Billion | 1.89 Billion | 1.51 Billion | 1.17 Billion | 1.17 Billion | 1 Billion |
| Capital Expenditure | -152.04 Million | -18.31 Million | -27.35 Million | -129.23 Million | -58.92 Million | -30.64 Million |
| Effect of forex changes on cash | -4.5 Million | 213.26 Thousand | 428.04 Thousand | 719.82 Thousand | -3.23 Million | -1.07 Million |
| Net cash flow / Change in cash | -673.22 Million | 387 Million | 333.4 Million | 187.28 Million | 170.1 Million | -368.03 Million |
| Free Cash Flow | 62.76 Million | 199.31 Million | 109.08 Million | 483.58 Million | 240.18 Million | -14.82 Million |
VMM
ENDO
RIBT
CENTRUM
UNI
FNFI